Sickle Cell
Protocol:D5136C00009
Condition or Disease: Sickle Cell Disease
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: A randomised, double-blind, parallel-group, multicenter, phase III study to evaluate the effect of ticagrelor bid versus placebo in reducing the number of VOCs in paediatric patients with sickle cell disease.
Principal I investigator: Nik Farahana Nik Abdul Rashid, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03615924
Sickle Cell
Protocol:GBT440-034
Condition or Disease: Sickle Cell Disease
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: An Open Label Extension Study GBT440 administered Orally to Patients with Sickle Cell Disease Who Have Participate in GBR440 Clinical Trials.
Principal I investigator: Alan Ikeda, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03573882
Sickle Cell
Protocol:GBT440-031
Condition or Disease: Sickle Cell Disease
Study Type: Interventional (Clinical Trial)
Status: Enrollment Paused
Study Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Subjects with Sickle Cell Disease
Principal I investigator: Alan Ikeda, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03036813
